Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma

Published:2017-09-21 Issue:5 Volume:59 Page:1133-1142
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Maziarz Richard T.¹,Hao Yanni²,Guerin Annie³,Gauthier Genevieve³,Gauthier-Loiselle Marjolaine³,Thomas Simu K.²,Eldjerou Lamis²

Affiliation:

1. Center for Hematologic Malignancies, Knight Cancer Institute Oregon Health & Science University (OHSU), Portland, OR, USA;

2. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;

3. Analysis Group, Inc, Montréal, QC, Canada

Funder

Novartis Pharmaceuticals Corporation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1375100

Reference26 articles.

1. Lymphoma Research Foundation [Internet]. Diffuse Large B-Cell Lymphoma (DLBCL); 2016 [cited Dec 2016]. Available from: http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6300153

2. World Health Organization (WHO) [Internet]. Diffuse large B-cell lymphoma (2014); 2016 [cited Dec 2016]. Available from: http://www.who.int/selection_medicines/committees/expert/20/applications/DiffuseLargeBCellLymphoma.pdf

3. Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines

4. Primary Mediastinal Large B-cell Lymphoma

5. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico;World Journal of Transplantation;2024-06-18

2. Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review;Transplantation and Cellular Therapy;2024-05

3. Perspectives on the Cost and Value of Stem Cell and Emerging Therapies;Comprehensive Hematology and Stem Cell Research;2024

4. Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective;Blood Advances;2023-12-06

5. Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma;Leukemia & Lymphoma;2023-05-25